nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—thyroid cancer	0.871	1	CbGbCtD
Carbachol—Corneal opacity—Vandetanib—thyroid cancer	0.0137	0.16	CcSEcCtD
Carbachol—Hyponatraemia—Vandetanib—thyroid cancer	0.0026	0.0305	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00259	0.0304	CcSEcCtD
Carbachol—Hyponatraemia—Sorafenib—thyroid cancer	0.00176	0.0206	CcSEcCtD
Carbachol—PLA2G4A—saliva-secreting gland—thyroid cancer	0.00167	0.135	CbGeAlD
Carbachol—Venous thrombosis—Epirubicin—thyroid cancer	0.00165	0.0193	CcSEcCtD
Carbachol—Arrhythmia—Vandetanib—thyroid cancer	0.0016	0.0188	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—thyroid cancer	0.00153	0.0179	CcSEcCtD
Carbachol—Muscle spasms—Vandetanib—thyroid cancer	0.0015	0.0176	CcSEcCtD
Carbachol—Abdominal discomfort—Sorafenib—thyroid cancer	0.00145	0.017	CcSEcCtD
Carbachol—Loss of consciousness—Vandetanib—thyroid cancer	0.00137	0.0161	CcSEcCtD
Carbachol—PLA2G4A—trachea—thyroid cancer	0.00129	0.104	CbGeAlD
Carbachol—Infection—Vandetanib—thyroid cancer	0.00127	0.0148	CcSEcCtD
Carbachol—CHRNA2—thyroid gland—thyroid cancer	0.00126	0.102	CbGeAlD
Carbachol—Necrosis—Epirubicin—thyroid cancer	0.00114	0.0133	CcSEcCtD
Carbachol—Abscess—Epirubicin—thyroid cancer	0.00113	0.0132	CcSEcCtD
Carbachol—Flushing—Sorafenib—thyroid cancer	0.00112	0.0131	CcSEcCtD
Carbachol—CHRM1—saliva-secreting gland—thyroid cancer	0.00112	0.0903	CbGeAlD
Carbachol—Dyspepsia—Vandetanib—thyroid cancer	0.00112	0.0131	CcSEcCtD
Carbachol—CHRNA2—head—thyroid cancer	0.00112	0.0901	CbGeAlD
Carbachol—Stinging—Epirubicin—thyroid cancer	0.0011	0.0129	CcSEcCtD
Carbachol—Pain—Vandetanib—thyroid cancer	0.00109	0.0128	CcSEcCtD
Carbachol—Arrhythmia—Sorafenib—thyroid cancer	0.00108	0.0127	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—thyroid cancer	0.00105	0.0123	CcSEcCtD
Carbachol—Abscess—Doxorubicin—thyroid cancer	0.00104	0.0122	CcSEcCtD
Carbachol—PLA2G4A—thyroid gland—thyroid cancer	0.00102	0.0822	CbGeAlD
Carbachol—Extravasation—Epirubicin—thyroid cancer	0.00102	0.0119	CcSEcCtD
Carbachol—Stinging—Doxorubicin—thyroid cancer	0.00102	0.0119	CcSEcCtD
Carbachol—Muscle spasms—Sorafenib—thyroid cancer	0.00101	0.0119	CcSEcCtD
Carbachol—Abdominal pain—Vandetanib—thyroid cancer	0.00101	0.0118	CcSEcCtD
Carbachol—Body temperature increased—Vandetanib—thyroid cancer	0.00101	0.0118	CcSEcCtD
Carbachol—CHRM3—saliva-secreting gland—thyroid cancer	0.001	0.0809	CbGeAlD
Carbachol—Syncope—Sorafenib—thyroid cancer	0.000945	0.0111	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—thyroid cancer	0.000945	0.0111	CcSEcCtD
Carbachol—Ulcer—Epirubicin—thyroid cancer	0.000942	0.011	CcSEcCtD
Carbachol—Loss of consciousness—Sorafenib—thyroid cancer	0.000926	0.0108	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—thyroid cancer	0.000875	0.0102	CcSEcCtD
Carbachol—Diarrhoea—Vandetanib—thyroid cancer	0.000872	0.0102	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—thyroid cancer	0.000872	0.0102	CcSEcCtD
Carbachol—CHRM1—trachea—thyroid cancer	0.000866	0.0697	CbGeAlD
Carbachol—Salivary hypersecretion—Epirubicin—thyroid cancer	0.000865	0.0101	CcSEcCtD
Carbachol—Infection—Sorafenib—thyroid cancer	0.000855	0.01	CcSEcCtD
Carbachol—Shock—Sorafenib—thyroid cancer	0.000846	0.0099	CcSEcCtD
Carbachol—Dizziness—Vandetanib—thyroid cancer	0.000843	0.00987	CcSEcCtD
Carbachol—Vomiting—Vandetanib—thyroid cancer	0.000811	0.00949	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00081	0.00948	CcSEcCtD
Carbachol—Rash—Vandetanib—thyroid cancer	0.000804	0.00941	CcSEcCtD
Carbachol—Dermatitis—Vandetanib—thyroid cancer	0.000803	0.0094	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000801	0.00937	CcSEcCtD
Carbachol—Headache—Vandetanib—thyroid cancer	0.000799	0.00935	CcSEcCtD
Carbachol—Nausea—Vandetanib—thyroid cancer	0.000757	0.00886	CcSEcCtD
Carbachol—Dyspepsia—Sorafenib—thyroid cancer	0.000757	0.00886	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—thyroid cancer	0.000751	0.00878	CcSEcCtD
Carbachol—Pain—Sorafenib—thyroid cancer	0.000736	0.00861	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—thyroid cancer	0.000695	0.00813	CcSEcCtD
Carbachol—Abdominal pain—Sorafenib—thyroid cancer	0.00068	0.00796	CcSEcCtD
Carbachol—Body temperature increased—Sorafenib—thyroid cancer	0.00068	0.00796	CcSEcCtD
Carbachol—CHRM2—head—thyroid cancer	0.000668	0.0537	CbGeAlD
Carbachol—Hyponatraemia—Epirubicin—thyroid cancer	0.000649	0.0076	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000647	0.00757	CcSEcCtD
Carbachol—PLA2G4A—lymph node—thyroid cancer	0.000635	0.0511	CbGeAlD
Carbachol—CHRM3—thyroid gland—thyroid cancer	0.000613	0.0493	CbGeAlD
Carbachol—CHRM1—head—thyroid cancer	0.000608	0.0489	CbGeAlD
Carbachol—Hyponatraemia—Doxorubicin—thyroid cancer	0.000601	0.00703	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000598	0.007	CcSEcCtD
Carbachol—Diarrhoea—Sorafenib—thyroid cancer	0.000589	0.00689	CcSEcCtD
Carbachol—Dizziness—Sorafenib—thyroid cancer	0.000569	0.00666	CcSEcCtD
Carbachol—Asthma—Epirubicin—thyroid cancer	0.000559	0.00654	CcSEcCtD
Carbachol—Vomiting—Sorafenib—thyroid cancer	0.000547	0.0064	CcSEcCtD
Carbachol—CHRM3—head—thyroid cancer	0.000544	0.0438	CbGeAlD
Carbachol—Rash—Sorafenib—thyroid cancer	0.000542	0.00635	CcSEcCtD
Carbachol—Dermatitis—Sorafenib—thyroid cancer	0.000542	0.00634	CcSEcCtD
Carbachol—Headache—Sorafenib—thyroid cancer	0.000539	0.00631	CcSEcCtD
Carbachol—Asthma—Doxorubicin—thyroid cancer	0.000517	0.00605	CcSEcCtD
Carbachol—Nausea—Sorafenib—thyroid cancer	0.000511	0.00598	CcSEcCtD
Carbachol—Sweating—Epirubicin—thyroid cancer	0.000478	0.00559	CcSEcCtD
Carbachol—Sweating—Doxorubicin—thyroid cancer	0.000442	0.00517	CcSEcCtD
Carbachol—Flushing—Epirubicin—thyroid cancer	0.000415	0.00486	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—thyroid cancer	0.0004	0.00468	CcSEcCtD
Carbachol—Flushing—Doxorubicin—thyroid cancer	0.000384	0.0045	CcSEcCtD
Carbachol—Flatulence—Epirubicin—thyroid cancer	0.000384	0.00449	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—thyroid cancer	0.000374	0.00438	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—thyroid cancer	0.00037	0.00433	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—thyroid cancer	0.000355	0.00416	CcSEcCtD
Carbachol—Syncope—Epirubicin—thyroid cancer	0.000349	0.00409	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—thyroid cancer	0.000347	0.00405	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—thyroid cancer	0.000342	0.00401	CcSEcCtD
Carbachol—Syncope—Doxorubicin—thyroid cancer	0.000323	0.00378	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000317	0.00371	CcSEcCtD
Carbachol—Infection—Epirubicin—thyroid cancer	0.000316	0.0037	CcSEcCtD
Carbachol—Shock—Epirubicin—thyroid cancer	0.000313	0.00366	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000307	0.0036	CcSEcCtD
Carbachol—Hypotension—Epirubicin—thyroid cancer	0.000297	0.00348	CcSEcCtD
Carbachol—Infection—Doxorubicin—thyroid cancer	0.000292	0.00342	CcSEcCtD
Carbachol—Shock—Doxorubicin—thyroid cancer	0.000289	0.00339	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000284	0.00333	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—thyroid cancer	0.00028	0.00327	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—thyroid cancer	0.000275	0.00322	CcSEcCtD
Carbachol—Pain—Epirubicin—thyroid cancer	0.000272	0.00318	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—thyroid cancer	0.000259	0.00303	CcSEcCtD
Carbachol—Pain—Doxorubicin—thyroid cancer	0.000252	0.00294	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—thyroid cancer	0.000251	0.00294	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—thyroid cancer	0.000251	0.00294	CcSEcCtD
Carbachol—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—thyroid cancer	0.000235	0.00759	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000233	0.00751	CbGpPWpGaD
Carbachol—Abdominal pain—Doxorubicin—thyroid cancer	0.000233	0.00272	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—thyroid cancer	0.000233	0.00272	CcSEcCtD
Carbachol—CHRM2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000228	0.00736	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CALCB—thyroid cancer	0.000221	0.00714	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CALCB—thyroid cancer	0.00022	0.00712	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CALCB—thyroid cancer	0.000218	0.00705	CbGpPWpGaD
Carbachol—Diarrhoea—Epirubicin—thyroid cancer	0.000218	0.00255	CcSEcCtD
Carbachol—PLA2G4A—PDGF Pathway—HRAS—thyroid cancer	0.000211	0.0068	CbGpPWpGaD
Carbachol—Dizziness—Epirubicin—thyroid cancer	0.00021	0.00246	CcSEcCtD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000209	0.00675	CbGpPWpGaD
Carbachol—Vomiting—Epirubicin—thyroid cancer	0.000202	0.00237	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—thyroid cancer	0.000201	0.00235	CcSEcCtD
Carbachol—Rash—Epirubicin—thyroid cancer	0.0002	0.00235	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—thyroid cancer	0.0002	0.00234	CcSEcCtD
Carbachol—Headache—Epirubicin—thyroid cancer	0.000199	0.00233	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—thyroid cancer	0.000195	0.00228	CcSEcCtD
Carbachol—PLA2G4A—Signaling by GPCR—CALCB—thyroid cancer	0.000189	0.0061	CbGpPWpGaD
Carbachol—Nausea—Epirubicin—thyroid cancer	0.000189	0.00221	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—thyroid cancer	0.000187	0.00219	CcSEcCtD
Carbachol—Rash—Doxorubicin—thyroid cancer	0.000185	0.00217	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—thyroid cancer	0.000185	0.00217	CcSEcCtD
Carbachol—Headache—Doxorubicin—thyroid cancer	0.000184	0.00216	CcSEcCtD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—BRAF—thyroid cancer	0.00018	0.00582	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00018	0.00582	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000175	0.00564	CbGpPWpGaD
Carbachol—Nausea—Doxorubicin—thyroid cancer	0.000175	0.00204	CcSEcCtD
Carbachol—PLA2G4A—Metabolism—MINPP1—thyroid cancer	0.000167	0.00539	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—PRKAR1A—thyroid cancer	0.00015	0.00484	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—thyroid cancer	0.000147	0.00475	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—HRAS—thyroid cancer	0.000143	0.00463	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NDUFA13—thyroid cancer	0.000142	0.00458	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000134	0.00434	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000134	0.00433	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—BRAF—thyroid cancer	0.000134	0.00432	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CHST14—thyroid cancer	0.000133	0.00431	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000133	0.00429	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—thyroid cancer	0.00013	0.0042	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—SST—thyroid cancer	0.00013	0.00419	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—PTEN—thyroid cancer	0.000127	0.0041	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—AKT1—thyroid cancer	0.000127	0.00409	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CALCB—thyroid cancer	0.000125	0.00404	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CALCB—thyroid cancer	0.000125	0.00402	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CALCB—thyroid cancer	0.000123	0.00398	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000123	0.00397	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.000123	0.00396	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—AKT1—thyroid cancer	0.000122	0.00394	CbGpPWpGaD
Carbachol—PLA2G4A—Phospholipid metabolism—PTEN—thyroid cancer	0.000117	0.00379	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CALCB—thyroid cancer	0.000113	0.00366	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—NRAS—thyroid cancer	0.000113	0.00366	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CALCB—thyroid cancer	0.000113	0.00365	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CALCB—thyroid cancer	0.000112	0.00362	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CALCB—thyroid cancer	0.000112	0.0036	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000108	0.00349	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—HPGD—thyroid cancer	0.000108	0.00347	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000107	0.00345	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TRIM33—thyroid cancer	0.000106	0.00342	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000105	0.00338	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000104	0.00337	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000104	0.00335	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000103	0.00333	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—TSHR—thyroid cancer	0.000102	0.00331	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—TSHR—thyroid cancer	0.000102	0.0033	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—TSHR—thyroid cancer	0.000101	0.00326	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MINPP1—thyroid cancer	0.0001	0.00323	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IFNA2—thyroid cancer	9.93e-05	0.00321	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—KRAS—thyroid cancer	9.75e-05	0.00315	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	9.42e-05	0.00304	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	9.39e-05	0.00303	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.38e-05	0.00303	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	9.3e-05	0.003	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.05e-05	0.00292	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—TSHR—thyroid cancer	8.74e-05	0.00282	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.72e-05	0.00282	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—PTCH1—thyroid cancer	8.71e-05	0.00281	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—PTCH1—thyroid cancer	8.68e-05	0.0028	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PRKAR1A—thyroid cancer	8.6e-05	0.00278	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—PTCH1—thyroid cancer	8.59e-05	0.00278	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NDUFA13—thyroid cancer	8.5e-05	0.00275	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—HRAS—thyroid cancer	8.29e-05	0.00268	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	8.04e-05	0.0026	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CHST14—thyroid cancer	7.99e-05	0.00258	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—SST—thyroid cancer	7.96e-05	0.00257	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—SST—thyroid cancer	7.94e-05	0.00256	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—SST—thyroid cancer	7.86e-05	0.00254	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CALCA—thyroid cancer	7.66e-05	0.00248	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CALCA—thyroid cancer	7.64e-05	0.00247	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—PPARG—thyroid cancer	7.61e-05	0.00246	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CALCA—thyroid cancer	7.57e-05	0.00244	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PTCH1—thyroid cancer	7.43e-05	0.0024	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TCF7L1—thyroid cancer	7.06e-05	0.00228	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.95e-05	0.00224	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—SST—thyroid cancer	6.8e-05	0.0022	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALCB—thyroid cancer	6.7e-05	0.00217	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALCB—thyroid cancer	6.68e-05	0.00216	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALCB—thyroid cancer	6.62e-05	0.00214	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CALCA—thyroid cancer	6.55e-05	0.00211	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HPGD—thyroid cancer	6.44e-05	0.00208	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TRIM33—thyroid cancer	6.36e-05	0.00205	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TRIM33—thyroid cancer	6.34e-05	0.00205	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TRIM33—thyroid cancer	6.27e-05	0.00203	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—TPR—thyroid cancer	6.18e-05	0.00199	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.18e-05	0.00199	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—HRAS—thyroid cancer	6.16e-05	0.00199	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PRKAR1A—thyroid cancer	6.08e-05	0.00196	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CDK1—thyroid cancer	5.92e-05	0.00191	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	5.92e-05	0.00191	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	5.9e-05	0.0019	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	5.84e-05	0.00189	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—TSHR—thyroid cancer	5.79e-05	0.00187	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—TSHR—thyroid cancer	5.77e-05	0.00186	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—TSHR—thyroid cancer	5.71e-05	0.00184	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.51e-05	0.00178	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—TSHR—thyroid cancer	5.25e-05	0.0017	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—TSHR—thyroid cancer	5.24e-05	0.00169	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—PTEN—thyroid cancer	5.22e-05	0.00169	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.21e-05	0.00168	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—TSHR—thyroid cancer	5.19e-05	0.00167	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	5.17e-05	0.00167	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TSHR—thyroid cancer	5.16e-05	0.00167	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PRKAR1A—thyroid cancer	5.15e-05	0.00166	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PRKAR1A—thyroid cancer	5.1e-05	0.00165	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	5.09e-05	0.00164	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PRKAR1A—thyroid cancer	5.08e-05	0.00164	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	5.08e-05	0.00164	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	5.03e-05	0.00162	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MEN1—thyroid cancer	4.86e-05	0.00157	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.64e-05	0.0015	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—SLC5A5—thyroid cancer	4.62e-05	0.00149	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—SST—thyroid cancer	4.5e-05	0.00145	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—SST—thyroid cancer	4.49e-05	0.00145	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTCH1—thyroid cancer	4.47e-05	0.00144	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTCH1—thyroid cancer	4.45e-05	0.00144	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—SST—thyroid cancer	4.44e-05	0.00143	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	4.41e-05	0.00143	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTCH1—thyroid cancer	4.41e-05	0.00142	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	4.4e-05	0.00142	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTCH1—thyroid cancer	4.39e-05	0.00142	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.33e-05	0.0014	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CALCA—thyroid cancer	4.33e-05	0.0014	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CALCA—thyroid cancer	4.32e-05	0.00139	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CALCA—thyroid cancer	4.28e-05	0.00138	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TCF7L1—thyroid cancer	4.24e-05	0.00137	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TCF7L1—thyroid cancer	4.23e-05	0.00137	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TCF7L1—thyroid cancer	4.19e-05	0.00135	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—SST—thyroid cancer	4.09e-05	0.00132	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—SST—thyroid cancer	4.07e-05	0.00132	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—SST—thyroid cancer	4.03e-05	0.0013	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SST—thyroid cancer	4.02e-05	0.0013	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CALCA—thyroid cancer	3.93e-05	0.00127	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CALCA—thyroid cancer	3.92e-05	0.00127	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—RXRA—thyroid cancer	3.88e-05	0.00125	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CALCA—thyroid cancer	3.88e-05	0.00125	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CALCA—thyroid cancer	3.87e-05	0.00125	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.8e-05	0.00123	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.79e-05	0.00122	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.78e-05	0.00122	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—NRAS—thyroid cancer	3.7e-05	0.0012	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TPR—thyroid cancer	3.7e-05	0.00119	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PRKAR1A—thyroid cancer	3.64e-05	0.00118	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TP53—thyroid cancer	3.56e-05	0.00115	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CDK1—thyroid cancer	3.56e-05	0.00115	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CDK1—thyroid cancer	3.55e-05	0.00115	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CDK1—thyroid cancer	3.51e-05	0.00113	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDK1—thyroid cancer	3.5e-05	0.00113	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.23e-05	0.00104	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.22e-05	0.00104	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—KRAS—thyroid cancer	3.19e-05	0.00103	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TSHR—thyroid cancer	3.1e-05	0.001	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TSHR—thyroid cancer	3.09e-05	0.000999	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TSHR—thyroid cancer	3.06e-05	0.000989	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PRKAR1A—thyroid cancer	3.05e-05	0.000986	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PRKAR1A—thyroid cancer	3.04e-05	0.000983	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PRKAR1A—thyroid cancer	3.01e-05	0.000973	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MEN1—thyroid cancer	2.92e-05	0.000942	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MEN1—thyroid cancer	2.91e-05	0.000939	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MEN1—thyroid cancer	2.88e-05	0.00093	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TP53—thyroid cancer	2.83e-05	0.000915	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRG1—thyroid cancer	2.81e-05	0.000907	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC5A5—thyroid cancer	2.77e-05	0.000894	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—HRAS—thyroid cancer	2.71e-05	0.000875	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTCH1—thyroid cancer	2.64e-05	0.000852	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTCH1—thyroid cancer	2.63e-05	0.00085	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTCH1—thyroid cancer	2.61e-05	0.000841	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TERT—thyroid cancer	2.52e-05	0.000814	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PPARG—thyroid cancer	2.45e-05	0.000792	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SST—thyroid cancer	2.41e-05	0.000779	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HIF1A—thyroid cancer	2.41e-05	0.000779	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SST—thyroid cancer	2.41e-05	0.000777	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—thyroid cancer	2.39e-05	0.000772	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SST—thyroid cancer	2.38e-05	0.000769	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—RXRA—thyroid cancer	2.33e-05	0.000752	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALCA—thyroid cancer	2.32e-05	0.00075	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALCA—thyroid cancer	2.32e-05	0.000748	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALCA—thyroid cancer	2.29e-05	0.000741	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—NRAS—thyroid cancer	2.13e-05	0.000686	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDK1—thyroid cancer	2.1e-05	0.000679	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDK1—thyroid cancer	2.1e-05	0.000677	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDK1—thyroid cancer	2.08e-05	0.00067	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—BRAF—thyroid cancer	2e-05	0.000645	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—thyroid cancer	1.93e-05	0.000623	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KRAS—thyroid cancer	1.83e-05	0.000591	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRG1—thyroid cancer	1.69e-05	0.000545	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRG1—thyroid cancer	1.68e-05	0.000543	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTEN—thyroid cancer	1.68e-05	0.000543	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRG1—thyroid cancer	1.67e-05	0.000538	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—thyroid cancer	1.55e-05	0.000502	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—thyroid cancer	1.52e-05	0.000489	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—thyroid cancer	1.51e-05	0.000488	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—thyroid cancer	1.5e-05	0.000483	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000475	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—thyroid cancer	1.46e-05	0.000471	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	1.45e-05	0.000468	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	1.45e-05	0.000467	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	1.43e-05	0.000462	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—thyroid cancer	1.41e-05	0.000454	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—thyroid cancer	1.37e-05	0.000443	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.28e-05	0.000412	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	1.27e-05	0.000411	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.26e-05	0.000407	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—thyroid cancer	1.26e-05	0.000405	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.2e-05	0.000388	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.2e-05	0.000386	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.19e-05	0.000383	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.000373	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.1e-05	0.000355	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	1.1e-05	0.000354	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.09e-05	0.00035	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—thyroid cancer	1.08e-05	0.000349	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—thyroid cancer	1.01e-05	0.000326	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—thyroid cancer	9.7e-06	0.000313	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—thyroid cancer	9.6e-06	0.00031	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	9.34e-06	0.000302	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.31e-06	0.000301	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	9.22e-06	0.000298	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—thyroid cancer	9.18e-06	0.000297	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.08e-06	0.000293	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	9.06e-06	0.000292	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	8.97e-06	0.00029	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—thyroid cancer	8.76e-06	0.000283	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—thyroid cancer	8.73e-06	0.000282	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—thyroid cancer	8.65e-06	0.000279	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—thyroid cancer	8.46e-06	0.000273	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—thyroid cancer	8.43e-06	0.000272	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.35e-06	0.00027	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.25e-06	0.000266	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	8.22e-06	0.000266	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	8.14e-06	0.000263	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—thyroid cancer	8.11e-06	0.000262	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—thyroid cancer	7.54e-06	0.000244	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—thyroid cancer	7.52e-06	0.000243	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.45e-06	0.00024	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.49e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.47e-06	0.000209	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.41e-06	0.000207	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—thyroid cancer	5.81e-06	0.000188	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—thyroid cancer	5.77e-06	0.000186	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—thyroid cancer	5.75e-06	0.000186	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—thyroid cancer	5.7e-06	0.000184	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.52e-06	0.000178	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.5e-06	0.000178	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.45e-06	0.000176	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—thyroid cancer	4.87e-06	0.000157	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—thyroid cancer	4.86e-06	0.000157	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—thyroid cancer	4.81e-06	0.000155	CbGpPWpGaD
